Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

https://www.globenewswire.com/news-release/2023/08/30/2734023/0/en/Zealand-Pharma-announces-designation-of-priority-review-by-the-US-FDA-for-dasiglucagon-in-congenital-hyperinsulinism.html

company announcement